Toi, M., Inoue, K., Masuda, N., Iwata, H., Sohn, J., Hae Park, I., . . . Sledge, G. W. (2021). Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2− advanced breast cancer: MONARCH 2 & 3 trials. Cancer Sci.
Stile di citazione ChicagoToi, Masakazu, et al. "Abemaciclib in Combination With Endocrine Therapy for East Asian Patients With HR+, HER2− Advanced Breast Cancer: MONARCH 2 & 3 Trials." Cancer Sci 2021.
Citazione MLAToi, Masakazu, et al. "Abemaciclib in Combination With Endocrine Therapy for East Asian Patients With HR+, HER2− Advanced Breast Cancer: MONARCH 2 & 3 Trials." Cancer Sci 2021.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.